FOLH1 and Familial prostate cancer: However, the sensitivity of PSMA PET/CT for the detection of lymph node metastases is moderate (33–91%), most likely due to the limitations in the spatial resolution to detect small (< 3 mm) lymph node tumour deposits in primary as well as recurrent prostate cancer [13].